ClinVar Miner

Submissions for variant NM_000535.7(PMS2):c.1882C>T (p.Arg628Ter) (rs63750451)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 8
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV000218575 SCV000277667 pathogenic Hereditary cancer-predisposing syndrome 2017-11-14 criteria provided, single submitter clinical testing Lines of evidence used in support of classification: Alterations resulting in premature truncation (e.g.reading frame shift, nonsense)
Color RCV000218575 SCV000905473 pathogenic Hereditary cancer-predisposing syndrome 2018-02-07 criteria provided, single submitter clinical testing
DNA and Cytogenetics Diagnostics Unit,Erasmus Medical Center RCV000009823 SCV000745188 pathogenic Hereditary nonpolyposis colorectal cancer type 4 2016-03-16 criteria provided, single submitter clinical testing
Diagnostic Laboratory, Department of Genetics,University Medical Center Groningen RCV000009823 SCV000734561 pathogenic Hereditary nonpolyposis colorectal cancer type 4 no assertion criteria provided clinical testing
GeneDx RCV000220439 SCV000279234 pathogenic not provided 2018-07-31 criteria provided, single submitter clinical testing This pathogenic variant is denoted PMS2 c.1882C>T at the cDNA level and p.Arg628Ter (R628X) at the protein level. The substitution creates a nonsense variant, which changes an Arginine to a premature stop codon (CGA>TGA), and is predicted to cause loss of normal protein function through either protein truncation or nonsense-mediated mRNA decay. This variant has been reported in several individuals with Lynch syndrome (Hendriks 2006, ten Broeke 2015, Suerink 2015) and is considered pathogenic.
International Society for Gastrointestinal Hereditary Tumours (InSiGHT) RCV000076834 SCV000108321 pathogenic Lynch syndrome 2013-09-05 reviewed by expert panel research Coding sequence variation resulting in a stop codon
Invitae RCV000524451 SCV000551972 pathogenic Hereditary nonpolyposis colon cancer 2018-12-10 criteria provided, single submitter clinical testing This sequence change creates a premature translational stop signal (p.Arg628*) in the PMS2 gene. It is expected to result in an absent or disrupted protein product. This variant is present in population databases (rs63750451, ExAC 0.02%). This particular variant has been reported in the literature in individuals and families affected with Lynch syndrome (PMID: 16472587, 26110232, 25512458, 27435373, 27589204) and in the homozygous state in an individual affected with constitutional mismatch repair deficiency syndrome (PMID: 19283792). ClinVar contains an entry for this variant (Variation ID: 9242). Loss-of-function variants in PMS2 are known to be pathogenic (PMID: 21376568, 24362816). For these reasons, this variant has been classified as Pathogenic.
OMIM RCV000009823 SCV000030044 pathogenic Hereditary nonpolyposis colorectal cancer type 4 2006-02-01 no assertion criteria provided literature only

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.